Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
Associated filings
- 25 Mar 22 424B5 Prospectus supplement for primary offering
- 4 Jan 21 EFFECT Notice of effectiveness
-
18 Dec 20 S-3 Shelf registration
EIGRQ similar filings
Filing view
External links
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
The Board of Directors
Eiger BioPharmaceuticals, Inc:
We consent to the use of our report with respect to the consolidated financial statements and the effectiveness of internal control over financial reporting incorporated by reference herein and to the reference to our firm under the heading “Experts” in the Registration Statement and Prospectus.
/s/ KPMG LLP
San Francisco, California
December 18, 2020